|
Regulations
& Codified CSA > USC > Part
A > Subchapter
I, Part A > Section 801A
Section 801a. Congressional Findings and Declarations:
Psychotropic Substances
The Congress makes the following findings and declarations:
(1) The Congress has long recognized the danger involved in the manufacture, distribution, and
use of certain psychotropic substances for nonscientific and nonmedical purposes, and has
provided strong and effective legislation to control illicit trafficking and to regulate legitimate
uses of psychotropic substances in this country. Abuse of psychotropic substances has become a
phenomenon common to many countries, however, and is not confined to national borders. It is,
therefore, essential that the United States cooperate with other nations in establishing effective
controls over international traffic in such substances.
(2) The United States has joined with other countries in executing an international treaty, entitled
the Convention on Psychotropic Substances and signed at Vienna, Austria, on February 21, 1971,
which is designed to establish suitable controls over the manufacture, distribution, transfer, and
use of certain psychotropic substances. The Convention is not self-executing, and the obligations
of the United States thereunder may only be performed pursuant to appropriate legislation. It is
the intent of the Congress that the amendments made by this Act, together with existing law, will
enable the United States to meet all of its obligations under the Convention and that no further
legislation will be necessary for that purpose.
(3) In implementing the Convention on Psychotropic Substances, the Congress intends that,
consistent with the obligations of the United States under the Convention, control of
psychotropic substances in the United States should be accomplished within the framework of
the procedures and criteria for classification of substances provided in the Comprehensive Drug
Abuse Prevention and Control Act of 1970. This will insure that (A) the availability of
psychotropic substances to manufacturers, distributors, dispensers, and researchers for useful and
legitimate medical and scientific purposes will not be unduly restricted; (B) nothing in the
Convention will interfere with bona fide research activities; and (C) nothing in the Convention
will interfere with ethical medical practice in this country as determined by the Secretary of
Health and Human Services on the basis of a consensus of the views of the American medical
and scientific community.
(Pub.L. 95-633, Title I, Section 101, Nov. 10, 1978, 92 Stat. 3768; Pub.L. 96-88, Title V, Section
509, Oct. 17, 1979, 93 Stat. 695.)
EDITORIAL NOTES
References in Text. This Act, referred to in par. (2), is Pub.L. 95-633, Nov. 10, 1978, 92 Stat.
2768, known as the Psychotropic Substances Act of 1978, which enacted this section and
sections 830, and 852 of this title, amended sections 352, 802, 811, 812, 823, 827, 841 to 843,
872, 881, 952, 953, and 965 of Title 21, U.S.C.A., Food and Drugs, and section 242 of Title 42,
U.S.C.A., The Public Health and Welfare, and enacted provisions set out as notes under this
section and sections 801, 812, and 830 of Title 21.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, referred to in par. (3), is
Pub.L. 91-513, Oct. 27, 1970, 84 Stat. 1236, as amended, which is classified principally to this
chapter.
Change of Name. "Secretary of Health and Human Services" was substituted for "Secretary of
Health, Education, and Welfare" on authority of Pub.L. 96-88, Title V, Section 509, Oct. 17,
1979, 93 Stat. 695, which is classified to section 3508 of Title 20, U.S.C.A., Education.
Back to Top
NOTICE: This is an
unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
